Position in GSK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,671,359
-$88,263 QoQ
Shares Held
31,884
+0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#286
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Greenwich Wealth Management LLC holds $17,338,236 across 10 Drug Manufacturers - General names. GSK ranks #5 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
14,267 | $3,590,147 | |
| 2 | PFE |
Pfizer Inc
|
140,297 | $3,378,351 | |
| 3 | LLY |
ELI LILLY & Co
|
2,759 | $3,309,227 | |
| 4 | NVS |
Novartis AG
|
11,294 | $1,769,995 | |
| 5 | GSK |
GSK plc
This page
|
31,884 | $1,671,359 | |
| 6 | JNJ |
Johnson & Johnson
|
4,468 | $1,134,737 | |
| 7 | MRK |
Merck & Co., Inc.
|
7,081 | $909,908 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,467 | $817,040 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,671,359 | 31,884 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,759,622 | 31,883 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,564,425 | 31,901 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,376,804 | 31,900 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,224,921 | 31,899 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,235,767 | 31,899 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,113,895 | 32,936 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,310,122 | 32,048 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,233,809 | 32,047 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,375,998 | 32,097 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,189,514 | 32,097 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,167,141 | 32,197 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $1,148,178 | 32,216 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,146,245 | 32,216 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $1,132,913 | 32,240 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $948,823 | 32,240 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,729,201 | 40,502 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,730,393 | 40,502 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,756,645 | 40,613 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $1,522,027 | 40,613 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $1,564,249 | 40,052 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $1,402,010 | 40,052 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,445,614 | 40,052 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,504,454 | 40,752 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $1,630,358 | 40,752 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,588,771 | 42,752 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||